Other Species / Isoforms
  KLF5 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K31-ub
EPVFAQLkPVLGAAN
0 1
KLF5 (human) EPVFAQLkPVLGAAN K31-ub
KLF5 (mouse) EPVFAQLKPVLGAAN K31
KLF5 (rat) gap -
R57-m2
ELKHAHHrPQAQPAP
Downstream
1 0
Effects on Modified Protein
  • protein stabilization
Effects on Biological Processes:
  • cell growth, induced
KLF5 (human) ELKHAHHrPQAQPAP R57-m2
KLF5 (mouse) DLKHAHHHPPAPPPA H57
KLF5 (rat) gap -
K110-ub
VPIIPEHkKYRRDsA
0 1
KLF5 (human) VPIIPEHkKYRRDsA K110-ub
KLF5 (mouse) VPIISEHKKYRRDSA K99
KLF5 (rat) VPIISEHKKYRRDSA K19
K110-sm
VPIIPEHkKYRRDsA
0 1
KLF5 (human) VPIIPEHkKYRRDsA K110-sm
KLF5 (mouse) VPIISEHKKYRRDSA K99
KLF5 (rat) VPIISEHKKYRRDSA K19
S116-p
HkKYRRDsASVVDQF
0 1
KLF5 (human) HkKYRRDsASVVDQF S116-p
KLF5 (mouse) HKKYRRDSASVVDQF S105
KLF5 (rat) HKKYRRDSASVVDQF S25
S153-p
LRTGLYKsQRPCVTH
Downstream
1 1
Effects on Biological Processes:
  • transcription, altered
KLF5 (human) LRTGLYKsQRPCVTH S153-p
KLF5 (mouse) LRTGLYKSQRPCVTQ S142
KLF5 (rat) LRTGLYKSQRPCVTQ S62
K162-sm
RPCVTHIkTEPVAIF
2 0
KLF5 (human) RPCVTHIkTEPVAIF K162-sm
KLF5 (mouse) RPCVTQIkTEPVTIF K151-sm
KLF5 (rat) RPCVTQIKTEPVTIF K71
K209-sm
EVNNIFIkQELPTPD
2 1
KLF5 (human) EVNNIFIkQELPTPD K209-sm
KLF5 (mouse) EVNNIFIkQELPIPD K202-sm
KLF5 (rat) EVNNIFIKQELPIPD K119
S303-p
QATYFPPsPPSSEPG
Upstream
Downstream
2 0
Effects on Modified Protein
  • molecular association, regulation
  • protein degradation
  • ubiquitination
Effects on Biological Processes:
  • carcinogenesis, altered
  • transcription, inhibited
Kinase, in vitro:
  • GSK3B (human)
Putative in vivo kinases:
  • GSK3B (human)
Treatment
  • KCl
  • lithium
  • mutation
KLF5 (human) QATYFPPsPPSSEPG S303-p
KLF5 (mouse) QATYFPPSPPSSEPG S292
KLF5 (rat) QATYFPPSPPSSEPG S209
T323-p
AEMLQNLtPPPSYAA
0 1
KLF5 (human) AEMLQNLtPPPSYAA T323-p
KLF5 (mouse) AEMLQNLTPPPSYAA T312
KLF5 (rat) AEMLQNLTPPPSYAA T229
T346-p
HNPNLPTtLPVNSQN
0 1
KLF5 (human) HNPNLPTtLPVNSQN T346-p
KLF5 (mouse) HNPNLPATLPVNSPT T335
KLF5 (rat) HNPNLPATLPVNSPN T252
Y359-p
QNIQPVRyNRRsNPD
0 1
KLF5 (human) QNIQPVRyNRRsNPD Y359-p
KLF5 (mouse) PTLPPVRyNRRsNPD Y348-p
KLF5 (rat) PNIQPVRYNRRSNPD Y265
S363-p
PVRyNRRsNPDLEkR
0 1
KLF5 (human) PVRyNRRsNPDLEkR S363-p
KLF5 (mouse) PVRyNRRsNPDLEKR S352-p
KLF5 (rat) PVRYNRRSNPDLEKR S269
K369-ac
RsNPDLEkRRIHYCD
Upstream
Downstream
5 2
Effects on Modified Protein
  • protein degradation
  • protein stabilization
  • ubiquitination
Effects on Biological Processes:
  • cell differentiation, induced
  • cell growth, induced
  • cell growth, inhibited
  • transcription, altered
  • transcription, induced
  • transcription, inhibited
Regulatory protein:
  • DANCR (human)
Treatment
  • TGF-beta
  • trichostatin_A
  • vorinostat
KLF5 (human) RsNPDLEkRRIHYCD K369-ac
KLF5 (mouse) RsNPDLEKRRIHFCD K358
KLF5 (rat) RSNPDLEKRRIHFCD K275
Y377-p
RRIHYCDyPGCTKVY
0 2
KLF5 (human) RRIHYCDyPGCTKVY Y377-p
KLF5 (mouse) RRIHFCDYNGCTKVY Y366
KLF5 (rat) RRIHFCDYDGCTKVY Y283
K391-ub
YTKSSHLkAHLRtHT
0 3
KLF5 (human) YTKSSHLkAHLRtHT K391-ub
KLF5 (mouse) YTKSSHLkAHLRTHT K380-ub
KLF5 (rat) YTKSSHLKAHLRTHT K297
T396-p
HLkAHLRtHTGEKPY
0 2
KLF5 (human) HLkAHLRtHTGEKPY T396-p
KLF5 (mouse) HLkAHLRTHTGEKPY T385
KLF5 (rat) HLKAHLRTHTGEKPY T302
S441-p
QCGVCNRsFsRSDHL
0 2
KLF5 (human) QCGVCNRsFsRSDHL S441-p
KLF5 (mouse) QCMVCQRSFSRSDHL S430
KLF5 (rat) QCVVCNRsFsRSDHL S347-p
S443-p
GVCNRsFsRSDHLAL
0 2
KLF5 (human) GVCNRsFsRSDHLAL S443-p
KLF5 (mouse) MVCQRSFSRSDHLAL S432
KLF5 (rat) VVCNRsFsRSDHLAL S349-p